JP2008524329A5 - - Google Patents

Download PDF

Info

Publication number
JP2008524329A5
JP2008524329A5 JP2007548319A JP2007548319A JP2008524329A5 JP 2008524329 A5 JP2008524329 A5 JP 2008524329A5 JP 2007548319 A JP2007548319 A JP 2007548319A JP 2007548319 A JP2007548319 A JP 2007548319A JP 2008524329 A5 JP2008524329 A5 JP 2008524329A5
Authority
JP
Japan
Prior art keywords
cancer
pharmaceutical composition
mammal
pharmaceutically acceptable
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2007548319A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008524329A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/045563 external-priority patent/WO2006068933A2/en
Publication of JP2008524329A publication Critical patent/JP2008524329A/ja
Publication of JP2008524329A5 publication Critical patent/JP2008524329A5/ja
Withdrawn legal-status Critical Current

Links

JP2007548319A 2004-12-21 2005-12-15 有糸分裂キネシン阻害剤 Withdrawn JP2008524329A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63772204P 2004-12-21 2004-12-21
PCT/US2005/045563 WO2006068933A2 (en) 2004-12-21 2005-12-15 Mitotic kinesin inhibitors

Publications (2)

Publication Number Publication Date
JP2008524329A JP2008524329A (ja) 2008-07-10
JP2008524329A5 true JP2008524329A5 (https=) 2008-12-11

Family

ID=36602225

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007548319A Withdrawn JP2008524329A (ja) 2004-12-21 2005-12-15 有糸分裂キネシン阻害剤

Country Status (7)

Country Link
US (1) US20080045492A1 (https=)
EP (1) EP1831176A2 (https=)
JP (1) JP2008524329A (https=)
CN (1) CN101084194A (https=)
AU (1) AU2005319455A1 (https=)
CA (1) CA2589827A1 (https=)
WO (1) WO2006068933A2 (https=)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007011647A2 (en) * 2005-07-15 2007-01-25 Kalypsys, Inc. Inhibitors of mitotic kinesin ksp
EP1950202A1 (en) * 2007-01-24 2008-07-30 Laboratorios del Dr. Esteve S.A. Substituted pyrazoline compounds, their preparation and use as medicaments with ACAT inhibition activity
US20100099712A1 (en) * 2007-01-17 2010-04-22 Laboratorios Del Dr. Esteve, S.A. Substituted pyrazoline compounds with acat inhibition activity
TW200934785A (en) 2007-10-19 2009-08-16 Schering Corp Compounds for inhibiting KSP kinesin activity
CN101918389A (zh) * 2007-11-02 2010-12-15 梅特希尔基因公司 组蛋白脱乙酰酶抑制剂
US9029411B2 (en) 2008-01-25 2015-05-12 Millennium Pharmaceuticals, Inc. Thiophenes and uses thereof
WO2010090716A1 (en) 2009-01-30 2010-08-12 Millennium Pharmaceuticals, Inc. Heteroaryls and their use as pi3k inhibitors
US8796314B2 (en) 2009-01-30 2014-08-05 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
US9090601B2 (en) 2009-01-30 2015-07-28 Millennium Pharmaceuticals, Inc. Thiazole derivatives
TW201217365A (en) 2010-08-11 2012-05-01 Millennium Pharm Inc Heteroaryls and uses thereof
US8859768B2 (en) 2010-08-11 2014-10-14 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
WO2012021611A1 (en) 2010-08-11 2012-02-16 Millennium Pharmaceuticals, Inc. Heteroaryls and uses thereof
TW201307309A (zh) 2010-10-13 2013-02-16 Millennium Pharm Inc 雜芳基化合物及其用途
BR112014006940A2 (pt) 2011-09-23 2017-04-04 Bayer Ip Gmbh uso de derivados de ácido 1-fenilpirazol-3-carboxílico 4-substituído como agentes contra estresse abiótico em plantas
TW201332989A (zh) * 2011-12-23 2013-08-16 Millennium Pharm Inc 雜芳基化合物及其用途
AR094929A1 (es) 2013-02-28 2015-09-09 Bristol Myers Squibb Co Derivados de fenilpirazol como inhibidores potentes de rock1 y rock2
CN105102448B (zh) 2013-02-28 2018-03-06 百时美施贵宝公司 作为rock1和rock2抑制剂的苯基吡唑衍生物
CN103992274A (zh) * 2014-04-18 2014-08-20 南京安美科技有限公司 合成选择性非甾体抗炎镇痛药Celebrex(塞来昔布)的方法
WO2026070814A1 (ja) * 2024-09-30 2026-04-02 大日本印刷株式会社 重合性液晶化合物及びその製造方法、重合性組成物、重合体、位相差フィルム及びその製造方法、転写用積層体、光学部材及びその製造方法、並びに表示装置

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60326248D1 (de) * 2002-07-17 2009-04-02 Cytokinetics Inc Verbindungen, zusammensetzungen und verfahren zur behandlung von zellulären proliferativen erkrankungen
CA2571572A1 (en) * 2004-07-01 2006-01-19 Merck & Co., Inc. Mitotic kinesin inhibitors
EP1868601A4 (en) * 2005-04-07 2008-12-10 Merck & Co Inc MITOTIC KINESINE HEMMER

Similar Documents

Publication Publication Date Title
JP2008524329A5 (https=)
ME00937B (me) Kombinovane terapije koje sadrže hinoksalinske inhibitore pi3k-alfa za upotrebu u liječenju kancera
NO2017019I2 (no) Enzalutamid eller et farmasøytisk akseptabelt salt derav
JP2004504381A5 (https=)
NO20033651L (no) Cancerbehandling
CL2011001863A1 (es) Compuestos derivados de fenilaminopirimidinas, inhibidores de quinasa del linfoma anaplastico; composicion farmaceutica; combinacion farmacologica; y su uso en el tratamiento de trastornos proliferativos tales como linfoma, osteosarcoma, melanoma o tumor de mama, renal y de prostata, entre otros (divisional solicitud 3552-07).
MX2010002179A (es) Composicion para el tratamiento de enfermedades neoplasicas.
ECSP099436A (es) Acilaminopirazoles como inhibidores de fgfr
NZ711695A (en) Nanoparticle comprising rapamycin and albumin as anticancer agent
JP2011515481A5 (https=)
IL179714A (en) Pharmaceutical preparation containing a history of 2-biphenyl-4-ram-3,2-dehydro-1h-quinazoline-4-on and its use in the preparation of cancer drugs and blood vessel formation
WO2008103470A3 (en) Oncogenic-ras-signal dependent lethal compounds
JP2004504382A5 (https=)
IL191832A (en) Pyridiazinone compounds and their use in the preparation of drugs for the treatment of tumors
IN2012DN01964A (https=)
JP2007510667A5 (https=)
JP2010523696A5 (https=)
WO2009046842A3 (de) Thialzolderivate zur behandlung von krebs
FR2869540B1 (fr) Compositions pharmaceutiques contenant des derives de b-carboline, et leur utilisation pour le traitement des cancers
DE602006010834D1 (de) Neue thiophensulfoximine zur behandlung von komplementvermittelten krankheiten und leiden
MX2007003104A (es) Nuevos derivados de ftalazinona, como inhibidores de cinasa aurora-a.
NO20081292L (no) Pentasykliske kinaseinhibitorer
EP2722060A3 (en) Guanylyl cyclase C ligands
YU11402A (sh) Nova primena docetaksela za lečenje hepatoma
IL178261A0 (en) Use of 5,10-methylene tetrahydrofolate for the treatment of cancer